Personal Research Database Bibliometric

Title: Der Urologe A

ISO Abbreviated Title:

JCR Abbreviated Title:

ISSN: 1433-0563

Issues/Year:

Journal Country/Territory:

Language:

Publisher:

Publisher Address:

Subject Categories:

: Impact Factor

? Labanaris, A.P., Krot, D., Schott, G.E., Helmschrott, P. and Zugor, V. (2007), Impact factors and publication time spans in urological journals. Der Urologe A, 46 (3), 297-300.

Full Text: 2007\Urology A46, 297.pdf

Abstract: the impact factor, cited half-life, and immediacy index are three important methods that can be used to demonstrate how a journal’s articles are cited over the course of a specific time span. These three factors thus represent instruments for measuring the importance and reputation of a scientific magazine. The goal of our study was to evaluate the constancy of journals specialized in the field of urology and to analyze those listed in the 2005 Journal Citation Report (JCR) using the standardized methods specified by the Institute of Scientific Information (ISI) and JCR. Primarily we wanted to examine the different time spans needed for publication of original papers submitted to certain journals; in more exact terms: the time span from submission of an article or original paper to its publication and from the time of acceptance of an original paper or article to its publication in a urological journal. Furthermore, we wanted to investigate the dynamics of urological journals regarding their impact factors for the years 2000-2005. The study was performed using the ISI JCR and the library as well as the online library of the Friedrich Alexander University in Erlangen. A very satisfactory development can be observed in the field of urology with the standardized methods of the (ISI) JCR.

Keywords: Bibliometric Evaluation, Cited Half-Life, Course, Development, Dynamics, Goal, Half-Life, Immediacy Index, Impact, Impact Factor, Impact Factors, Importance, Index, ISI, Journal, Methods, Paper, Publication, Publication Time Span, Urology

Title: Urologia Internationalis

ISO Abbreviated Title:

JCR Abbreviated Title:

ISSN:

Journal Country/Territory:

Language:

Publisher:

Publisher Address:

Subject Categories:

: Impact Factor

? Heidenreich, A., Albers, P., Classen, J., Graefen, M., Gschwend, J., Kotzerke, J., Krege, S., Lehmann, J., Rohde, D., Schmidberger, H., Uder, M. and Zeeb, H. (2010), Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: Recommendations of a multidisciplinary consensus meeting of the association of urological oncology of the German cancer society. Urologia Internationalis, 85 (1), 1-10.

Full Text: 2010\Uro Int85, 1.pdf

Abstract: Introduction: Imaging studies are an integral and important diagnostic modality to stage, to monitor and follow-up patients with metastatic urogenital cancer. The currently available guidelines on diagnosis and treatment of urogenital cancer do not provide the clinician with evidence-based recommendations for daily practice. Objectives: To develop scientifically valid recommendations with regard to the most appropriate imaging technique and the most useful time interval in metastatic urogenital cancer patients undergoing systemic therapy. Methods: A systematic literature review was performed searching MEDLINE, EMBASE and Web of Science databases using the terms prostate, renal cell, bladder and testis cancer in combination with the variables lymph node, lung, liver, bone metastases, chemotherapy and molecular therapy, and the search terms computed tomography, magnetic resonance imaging and positron emission tomography were applied. A total of 11,834 records were retrieved from all databases. The panel reviewed the records to identify articles with the highest level of evidence using the recommendation of the US Agency for Health Care Policy and Research. Conclusions: Contrast-enhanced computed tomography remains the standard imaging technique for monitoring of pulmonary, hepatic and lymph node metastases. Bone scintigraphy is still the most widely used imaging technique for the detection and follow-up of osseous lesions. for clinical trials it might be replaced by either PET-CT or MRI of the skeletal axis. Response assessment for patients treated with cytotoxic regime is best performed by the RECIST/WHO criteria; treatment response to molecular triggered therapy is best assessed by CT evaluating decrease in tumor size and density. Cross-sectional imaging studies for response assessment might be obtained after each 2 cycles of systemic therapy to early stratify responders from non-responders. Copyright (C) 2010 S. Karger AG, Basel.

Keywords: Assessment, Axial Skeleton, Bladder, Bladder Cancer, Bladder-Cancer, Bone, Bone Metastases, Cancer, Care, Chemotherapy, Clinical Trials, Computed Tomography, Computed-Tomography, Copyright, CT, Databases, Diagnosis, Follow-up, Germ Cell Tumors, Guidelines, Health, Imaging, Literature, Literature Review, Magnetic Resonance Imaging, Methods, Molecular, Monitoring, MRI, Multidisciplinary, Oncology, Patients, PET-CT, Policy, Positron-Emission-Tomography, Practice, Prognostic-Factors, Prostate Cancer, Prostate-Cancer, Pulmonary Nodules, Renal Cell Cancer, Renal-Cell Carcinoma, Research, Review, Science, Skeletal Scintigraphy, Systematic, Systematic Literature Review, Testis Cancer, Therapy, Therapy Response Assessment, Treatment, US, Web of Science, Whole-Body-MRI

? Lu, Z.P., Dong, Z.L., Ding, H.Z., Wang, H.Z., Ma, B.L. and Wang, Z.P. (2012), Tamsulosin for ureteral stones: A systematic review and meta-analysis of a randomized controlled trial. Urologia Internationalis, 89 (1), 107-115.

Full Text: 2012\Uro Int89, 107.pdf

Abstract: Background/Aims: To evaluate the efficacy of tamsulosin as a medical expulsive therapy of ureteral stones. Methods: We searched PubMed, EMBASE, the Cochrane Library, and ISI-Science Citation Index up to December 2011. All randomized controlled trials were identified in which patients were randomized to receive either tamsulosin or standard therapy with/without placebo for ureteral stones. Outcome measures assessed were overall stone expulsion rate (primary) and expulsion time, and the number of pain episodes (secondary). Three authors independently assessed study quality and extracted data. All data were analyzed using RevMan 5.0. Results: Twenty-nine trials with a total of 2,763 patients met the inclusion criteria. The pooled analysis showed a 19% improvement in stone clearance with tamsulosin. According to the doses of tamsulosin, the pooling effects of tamsulosin were analyzed, with a higher expulsion rate obtained than in controls. Compared with calcium channel blockers, there was a higher stone expulsion rate in tamsulosin. In addition, a shorter expulsion time, fewer colic episodes and adverse effects were observed. Conclusions: Tamsulosin is a safe and effective medical expulsive therapy choice for ureteral stones. It should be recommended for most patients with distal ureteral stones before stones are 10 mm in size. In future, high-quality multicenter, randomized and placebo-controlled trials are needed to evaluate the outcome. Copyright (C) 2012 S. Karger AG, Basel.

Keywords: Adverse Effects, Ag, Alfuzosin, Analysis, Authors, Calcium, Calcium Channel Blockers, Calculi, Choice, Citation, Colic, Criteria, Data, Dose Tamsulosin, Double-Blind, Effects, Efficacy, Improvement, Management, Medical, Medical Expulsive Therapy, Nifedipine, Outcome, Pain, Patients, Placebo, Placebo-Controlled Trial, Primary, Pubmed, Quality, Randomized, Randomized Controlled Trials, Review, Shock-Wave Lithotripsy, Size, Standard, Stone Expulsion, Tamsulosin, Therapy, Ureteral Stones, Urolithiasis

? Deng, S., Dong, Q., Wang, J. and Zhang, P. (2014), The role of mechanical bowel preparation before Ileal urinary diversion: A systematic review and meta-analysis. Urologia Internationalis, 92 (3), 339-348.

Full Text: 2014\Uro Int92, 339.pdf

Abstract: Background: Although the use of mechanical bowel preparation (MBP) is still widely promoted as the dogma before patients undergo ileal urinary diversion, an increasing number of clinical trials have suggested that there is no benefit. Thus, we performed a meta-analysis to evaluate the efficacy of MBP in ileal urinary diversion surgery. Methods: A literature search was performed in electronic databases, including PubMed, Embase, Science Citation Index Expanded as well as the Cochrane Library and the Cochrane Clinical Trials Registry, from 1966 to January 1, 2013. Clinical trials comparing outcomes of MBP versus no MBP for ileal urinary diversion surgery were included in the meta-analysis. Pooled odds ratios with 95% confidence intervals were calculated using the fixed- or random-effects models. Results: In total, two randomized controlled trials and five cohort studies were included in this meta-analysis. The primary outcomes, such as bowel leak and bowel obstruction, showed no statistical difference between the two groups. Additionally, the overall mortality rate and death rate related to operation also manifested that MBP does not offer an advantage over the no MBP. Conclusion: This meta-analysis suggests that MBP does not reduce the incidence of perioperative complications in urinary diversion compared with no MBP. However, large randomized controlled clinical trials are needed to confirm this finding. (C) 2014 S. Karger AG, Basel.

Keywords: Ag, Bowel, Bowel Obstruction, Bowel Preparation, Citation, Clinical, Clinical Trials, Cohort, Complications, Confidence, Confidence Intervals, Databases, Death, Efficacy, Elective Colorectal Surgery, Groups, Incidence, Intervals, Invasive Bladder-Cancer, Literature, Literature Search, Meta Analysis, Meta-Analysis, Metaanalysis, Methods, Models, Mortality, Mortality Rate, No Preparation, Operation, Outcomes, Patients, Perioperative Complications, Perioperative Management, Preparation, Primary, Pubmed, Radical Cystectomy, Radical Cystectomy, Randomized, Randomized Clinical-Trials, Randomized Controlled Trials, Results, Review, Science, Science Citation Index, Science Citation Index Expanded, Surgery, Systematic Review, Urethral Reconstruction, Urinary, Urinary Diversion

? Wu, T., Duan, X., Cao, C.X., Peng, C.D., Bu, S.Y. and Wang, K.J. (2014), The role of mirabegron in overactive bladder: A systematic review and meta-analysis. Urologia Internationalis, 93 (3), 326-337.

Full Text: 2014\Uro Int93, 326.pdf

Abstract: Objective: To present a systematic review assessing the efficacy and safety of mirabegron for overactive bladder (OAB). Materials and Methods: A literature search was performed using the Cochrane Library, MEDLINE, EMBASE and Science Citation Index Expanded. The literature reviewed included meta-analyses, randomized and nonrandomized prospective studies. We utilized mean difference (MD) to measure the mean number of incontinence episodes and the mean number of nnicturitions, and OAB questionnaire (OAB-q) and odds ratio (OR) to measure adverse events rates. We used the Cochrane Collaboration’s Review Manager 5.1 software for statistical analysis. Results: We identified six publications that strictly met our eligibility criteria. Meta-analysis of extractable data showed that mirabegron was more effective than placebo in treating OAB despite different drug dosages in the efficacy end points: mean number of incontinence episodes per 24 h (MD -0.54; 95% CI -0.63, -0.45; p = 0.001), mean number of micturitions per 24 h (MD -0.55; 95% CI -0.63, -0.47; p = 0.001), OAB-q (MD -4.49; 95% CI -6.27, -2.71; p = 0.001) and adverse events (OR 0.99; 95% CI 0.83, 1.19; p = 0.92). When compared to tolterodine, mirabegron was more effective in terms of mean number of incontinence episodes per 24 h (MD -0.25; 95% CI -0.43, -0.06; p = 0.009). However, there were no differences between mirabegron and tolterodine in mean number of micturitions per 24 h (MD -0.17; 95% CI -0.35,0.01; p = 0.07) and OAB-q (MD -1.09; 95% Cl -2.51, 0.33; p = 0.13). Mirabegron also had a lower adverse reaction rate (OR 0.9; 95% CI 0.8, 1.0; p = 0.04). Conclusions: In this diverse population, nnirabegron was an effective and safe pharmacologic therapy for OAB. (C) 2014 S. Karger AG, Basel.

Keywords: Adrenergic Beta-3 Receptor Agonists, Adverse Events, Ag, Analysis, Assessing, Beta(3)-Adrenoceptor Agonist, Bladder, Citation, Criteria, Data, Double-Blind, Drug, Efficacy, Embase, Events, Incontinence, Literature, Literature Search, Lower Urinary Tract Symptoms, Management, Materials, Measure, Medline, Meta Analysis, Meta-Analysis, Metaanalysis, Methods, Mirabegron, Odds Ratio, Overactive Bladder, Phase-Iii, Placebo, Population, Prospective, Prospective Studies, Publications, Questionnaire, Randomized, Rates, Results, Review, S, Safety, Science, Science Citation Index, Science Citation Index Expanded, Software, Statistical Analysis, Systematic, Systematic Review, Therapy, Trials, Urinary-Tract Symptoms